"Reducing opioid overdose deaths is a top priority for the FDA," Mike Davis M.D., Ph.D., from the FDA Center for Drug Evaluation and Research, said in a statement. "Today's approval of an additional ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the ...
Rextovy joins Narcan and RiVive as OTC intranasal naloxone options, enabling layperson administration and potentially improving time-to-reversal in community settings. US overdose epidemiology shows a ...
Add Yahoo as a preferred source to see more of our stories on Google. WASHINGTON (KTAL/KMSS) — The U.S. Food and Drug Administration has approved another over-the-counter naloxone nasal spray that can ...
The U.S. Food and Drug Administration on June 16, 2026 cleared Rextovy — a 4 milligram naloxone hydrochloride nasal spray made by Amphastar Pharmaceuticals — for over-the-counter sale, making it the ...
WASHINGTON — The U.S. Food and Drug Administration (FDA) announced Tuesday that it has approved Rextovy, a 4-milligram naloxone hydrochloride nasal spray, for over-the-counter sale, expanding access ...
The Food and Drug Administration approved Tuesday a third over-the-counter version of the naloxone nasal spray, which can be used to reverse an opioid overdose. The FDA touted the move as one that ...
WASHINGTON(KTAL/KMSS) — The U.S. Food and Drug Administration has approved another over-the-counter naloxone nasal spray that can be used to reverse opioid overdoses. Naloxone is a medication that ...
The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the agency said could save lives and reduce costs. The agency approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results